title: Programmed hypertension in rats treated with a NF-κB inhibitor during nephrogenesis: renal mechanisms.
abstract: Suppression of the renin-angiotensin system (RAS) during murine lactation causes progressive renal injury, indicating a physiological action of angiotensin II on nephrogenesis. The nuclear factor NF-κB system is one of the main intracellular mediators of angiotensin II. We investigated whether inhibition of this system with pyrrolidine dithiocarbamate (PDTC) during rat nephrogenesis would lead to similar hypertension and renal injury as observed with RAS suppressors. Immediately after delivery, 32 Munich-Wistar dams, each nursing 6 male pups, were divided into 2 groups: C, untreated, and PDTC, receiving PDTC, 280 mg kg(-1) day(-1) orally, during 21 days. After weaning, the offspring were followed until 10 months of age without treatment. Adult rats that received neonatal PDTC exhibited stable hypertension and myocardial injury, without albuminuria. To gain additional insight into this process, the renal expression of RAS components and sodium transporters were determined by quantitative real-time PCR (qRT-PCR) at 3 and 10 months of life. Renal renin and angiotensinogen were upregulated at 3 and downregulated at 10 months of age, suggesting a role for early local RAS activation. Likewise, there was early upregulation of the proximal sodium/glucose and sodium/bicarbonate transporters, which abated later in life, suggesting that additional factors sustained hypertension in the long run. The conclusions drawn from the findings were as follows: (1) an intact NF-κB system during nephrogenesis may be essential to normal renal and cardiovascular function in adult life; (2) neonatal PDTC represents a new model of hypertension, lacking overt structural injury or functional impairment of the kidneys; and (3) hypertension in this model seems associated with early temporary activation of renal RAS and sodium transporters.
authors.affiliation: Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
authors.forename: Daniele
authors.initials: D
authors.lastname: Canale
authors.forename: Mariliza V
authors.initials: MV
authors.lastname: Rodrigues
authors.forename: Daniele N
authors.initials: DN
authors.lastname: Ferreira
authors.forename: Flavia G
authors.initials: FG
authors.lastname: Machado
authors.forename: Mariana M
authors.initials: MM
authors.lastname: Veras
authors.forename: Denise M A C
authors.initials: DM
authors.lastname: Malheiros
authors.forename: José E
authors.initials: JE
authors.lastname: Krieger
authors.forename: Clarice K
authors.initials: CK
authors.lastname: Fujihara
authors.forename: Gabriela
authors.initials: G
authors.lastname: Venturini
authors.forename: Roberto
authors.initials: R
authors.lastname: Zatz
mesh_terms: D000818:Animals; D005260:Female; D006973:Hypertension / Q000209:etiology*; D007668:Kidney / Q000254:growth & development*; D008297:Male; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000502:physiology*; D011392:Proline / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D012084:Renin-Angiotensin System / Q000502:physiology; D012964:Sodium / Q000378:metabolism; D013859:Thiocarbamates / Q000494:pharmacology
chemical_list: D016328:NF-kappa B; D013859:Thiocarbamates; C066229:prolinedithiocarbamate; D011392:Proline; D012964:Sodium